0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover2437.85%IV596.06%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.5159Delta0.4580Gamma2.87Leverage Ratio-0.0768Theta0.0000Rho1.48Eff Leverage0.0001Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet